Markets

CALGARY, AB, June 3, 2021 /CNW/ – Alvopetro Energy Ltd. (TSXV: ALV) (OTCQX: ALVOF) announces May sales volumes, updated and improved 2021 EBITDA guidance, an operational update and plans to repay an additional $3.5 million of our outstanding credit facility balance. All references herein to $ refer to United States dollars, unless otherwise stated.Corey Ruttan, President and CEO commented: “With ongoing strong operational performance and an improved pricing outlook, I am very pleased to revise our EBITDA expectations upward. At the same time, as we fine-tune the phasing of capital spend relating to our exploration wells, we are seizing the opportunity to accelerate debt repayment, and now anticipate we will have repaid nearly 40% of our loan within less than a year of commencing production.”May Sales VolumesMay sales volumes averaged 2,353 boepd based on field estimates, including natural gas sales of 13.4 mmcfpd, associated natural gas liquids sales from condensate of 109 bopd, and oil sales of 10 bopd from our Bom Lugar field.  May sales increased 2% from our average April sales volumes of 2,313 boepd and increased 8% from our average Q1 2020 sales volumes of 2,175 boepd. 2021 EBITDA GuidanceWe expect our sales volumes to continue at rates

Warren Buffett (left) and Bill Gates are coming together to build a nuclear reactor in Wyoming. Frederic J. Brown/Getty; Insider

Heavily-shorted electric vehicle stocks such as Workhorse Group Inc (NASDAQ:WKHS) and Lordstown Motors Corp (NASDAQ:RIDE) surged on Wednesday on a trading day that saw huge gains in retail-investor favorites. What Happened: Workhorse with a short interest valued at $47.54 million or 41.93% of float topped the list of MarketWatch’s most shorted stocks. Short interest in Lordstown was valued at $34.24 million or 30.82% of the float. The EV firm was listed among the most shorted names. Workhorse shares rose 16.23% in the after-hours session on Wednesday to $13.39 after closing nearly 19.6% higher at $11.52 in the regular session. Lordstown shares closed 19.75% higher to $12.37 in the regular session on Wednesday and declined 1.37% in the after-hours trading to $12.20. EV stocks were surging in an environment where so-called stonks such as AMC Entertainment Holdings Inc (NYSE:AMC), GameStop Corp (NYSE:GME), and BlackBerry Ltd (NYSE:BB) saw spectacular gains on Wednesday amid a retail investor-led frenzy. Why It Matters: EV stocks have been lackluster this year with segment leader Tesla Inc (NASDAQ:TSLA) down 14.2% since the year began. Workhorse is down 41.8% and Lordstown 38.3% in a similar period. Workhorse stock has been under pressure after the company lost a lucrative

MINNEAPOLIS, June 3, 2021 /PRNewswire/ — Eyesafe Inc, a global leader in low blue light solutions for consumer electronics, today announced that GIGABYTE Technology, one of the world’s leading manufacturers of computer hardware, has successfully certified five gaming monitors that meet the Eyesafe® Display Standards. The five GIGABYTE Eyesafe® Certified models are the AORUS FI32Q, M28U, M32Q, G24F, and the forthcoming AORUS FI32U. These models will mark GIGABYTE’s first-ever monitors that are designed to meet the certification requirements for the TÜV Rheinland Eyesafe® Display Standards, the globally-recognized and most advanced set of requirements for blue light management and color performance in the consumer electronics industry. The Eyesafe® Standards were developed in conjunction with leading ophthalmologists, optometrists, and engineers who have serious concerns about potential risks from excess exposure to high-energy blue light. “GIGABYTE’s move to put health at the center of product design demonstrates tremendous foresight.”  -Justin Barrett, CEO”Health and safety are of paramount concern at GIGABYTE,” remarked Ming-Hsiung Liu, the Vice Chairman at GIGABYTE. “Our company is proud to introduce Eyesafe Certified gaming monitors, helping to reduce the risk of blue light and promote eye comfort for gamers. GIGABYTE is committed to the health and well-being of our consumers.””I want to

Nano One and Johnson Matthey announce the signing of a Joint Development Agreement. Co-development of next generation products and processes for Johnson Matthey’s eLNO® family of nickel-rich advanced cathode materials using Nano One’s patented One-Pot process. Includes detailed commercialization study for pre-pilot, pilot and scaled up production. Builds on the successful technical reviews and evaluations conducted by Nano One and JM over the past year. LONDON, June 3, 2021 /PRNewswire/ — Nano One® Materials Corp. (Nano One), a clean technology innovator in battery materials, and Johnson Matthey (JM), a global leader in sustainable technologies, today announced a joint development agreement. Under this agreement the companies will co-develop next generation products and processes for Johnson Matthey’s eLNO® family of nickel-rich advanced cathode materials using Nano One’s patented One-Pot process and coated nanocrystal technology, for the low-cost, low-carbon footprint production of high-performance lithium ion battery cathode materials.  JM has already made significant progress in the commercialisation of its family of nickel rich advanced cathode materials and has set a new standard in the sustainable production of battery cathode materials.  Nano One’s patented One-Pot process is designed to form a type of cathode material known as “coated single crystal” which can deliver increased

NEW YORK, June 3, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ: VRCA).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Verrica and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action]On June 1, 2021, Verrica issued a press release announcing that the U.S. Food and Drug Administration (“FDA”) extended the review period by three months for its New Drug Application (“NDA”) of VP-102 for the treatment of molluscum contagiosum (molluscum), a highly contagious viral skin disease.  Specifically, the press release indicated that “[o]n May 26, the company was informed by the FDA that the information submitted has been designated a major amendment, and therefore, the FDA will take an additional three months to review the submitted information.”  The press release further stated that “[t]he Prescription Drug User Fee Act (PDUFA) goal date has also been postponed by three months to September 23, 2021.”   On this news, Verrica’s stock price fell $0.96 per share, or 8.52%, to close at $10.30 per share on June 1, 2021.The

– The 28 systems to be deployed across KRC’s three laboratory sites will test about 94% of the country’s blood donations- They will run the Procleix Ultrio Elite Assay, an advanced nucleic acid test (NAT) ensuring donation safety by detecting the potential presence of the most important infectious pathogens in a single, simultaneous test- Grifols has recently expanded its transfusion safety excellence in the region, with more countries entrusting it to safeguard their blood suppliesBARCELONA, Spain, June 3, 2021 /PRNewswire/ — Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and innovative diagnostic solutions, today announced it will provide the Korean Red Cross (KRC) with its industry-leading Procleix Panther System running nucleic acid testing (NAT) technology to help ensure the safety of South Korea’s blood supply. As part of the KRC contract, Grifols will deliver 28 Procleix Panther Systems that will be deployed during the following months across the humanitarian organization’s three laboratory sites in South Korea. When fully operational, they will test about 94% of the country’s blood donations, which are needed mostly for transfusions. The Procleix Panther Systems are known for their reliability, scalability and versatility, providing high throughput with

US$200 million project to fully integrate Cargill’s palm supply chain and ensure sustainable product volumes for future growthSINGAPORE, June 3, 2021 /PRNewswire/ — Cargill is building a new US$200 million palm oil refinery in Lampung, Indonesia, which will accelerate Cargill’s efforts to develop a sustainable palm supply chain and provide verified deforestation free products to customers. The new refinery will play a key role in connecting sustainable crude palm oil production in Indonesia to demands in North America and Europe through a fully integrated supply chain from plantation to customer. With the new refinery, Cargill will be able to meet customers’ evolving expectations around sustainability and transparency by guaranteeing traceability to plantation and improved product quality standards.Palm oil, an important ingredient in nourishing the world’s population, has experienced strong demand in recent years, with Indonesia as the largest producer and exporter.  Palm oil is a high yielding and highly versatile oil that is not only used as cooking oil, but also used to create flavour and texture in many foods, and works as a stabilizing, binding and foaming agent in many everyday household products.Construction for the new state-of-the-art facility has commenced and operations are expected to be completed in late 2022.